Combination strategies with PD-1/PD-L1 blockade: current advances and future directions von Yi, Ming, Zheng, Xiaoli, Niu, Mengke, Zhu, Shuangli, Ge, Hong, Wu, Kongming

Volltext

Regulation of PD-L1 expression in the tumor microenvironment von Yi, Ming, Niu, Mengke, Xu, Linping, Luo, Suxia, Wu, Kongming

Volltext

Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy von Wu, Yuze, Yi, Ming, Niu, Mengke, Mei, Qi, Wu, Kongming

Volltext

CD44 as a tumor biomarker and therapeutic target von Xu, Hanxiao, Niu, Mengke, Yuan, Xun, Wu, Kongming, Liu, Aiguo

Volltext

Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer von Niu, Mengke, Liu, Yiming, Yi, Ming, Jiao, Dechao, Wu, Kongming

Volltext

The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-beta and PD-L1 von Yi, Ming, Zhang, Jing, Li, Anping, Niu, Mengke, Yan, Yongxiang, Jiao, Ying, Luo, Suxia, Zhou, Pengfei, Wu, Kongming

Volltext

Combine and conquer: manganese synergizing anti-TGF-beta/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers von Yi, Ming, Niu, Mengke, Zhang, Jing, Li, Shiyu, Zhu, Shuangli, Yan, Yongxiang, Li, Ning, Zhou, Pengfei, Chu, Qian, Wu, Kongming

Volltext

TGF-β: A novel predictor and target for anti-PD-1/PD-L1 therapy von Yi, Ming, Li, Tianye, Niu, Mengke, Wu, Yuze, Zhao, Zhenyu, Wu, Kongming

Volltext

Exploiting innate immunity for cancer immunotherapy von Yi, Ming, Li, Tianye, Niu, Mengke, Mei, Qi, Zhao, Bin, Chu, Qian, Dai, Zhijun, Wu, Kongming

Volltext

Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC von Niu, Mengke, Yi, Ming, Li, Ning, Luo, Suxia, Wu, Kongming

Volltext

Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors von Yi, Ming, Niu, Mengke, Wu, Yuze, Ge, Hong, Jiao, Dechao, Zhu, Shuangli, Zhang, Jing, Yan, Yongxiang, Zhou, Pengfei, Chu, Qian, Wu, Kongming

Volltext

Anti-TGF-β/PD-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple-negative breast cancer von Yi, Ming, Wu, Yuze, Niu, Mengke, Zhu, Shuangli, Zhang, Jing, Yan, Yongxiang, Zhou, Pengfei, Dai, Zhijun, Wu, Kongming

Volltext

Epidemiological trends of women's cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study von Yi, Ming, Li, Tianye, Niu, Mengke, Luo, Suxia, Chu, Qian, Wu, Kongming

Volltext

Advances of Targeted Therapy for Hepatocellular Carcinoma von Niu, Mengke, Yi, Ming, Li, Ning, Wu, Kongju, Wu, Kongming

Volltext

Bispecific antibody targeting TGF-β and PD-L1 for synergistic cancer immunotherapy von Li, Tianye, Wang, Xinrun, Niu, Mengke, Wang, Mingli, Zhou, Jianwei, Wu, Kongming, Yi, Ming

Volltext

CAR-NK cells for cancer immunotherapy: recent advances and future directions von Li, Tianye, Niu, Mengke, Zhang, Weijiang, Qin, Shuang, Zhou, Jianwei, Yi, Ming

Volltext

The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling von Li, Tianye, Niu, Mengke, Zhou, Jianwei, Wu, Kongming, Yi, Ming

Volltext

STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance von Li, Tianye, Zhang, Weijiang, Niu, Mengke, Wu, Yuze, Deng, Xinyue, Zhou, Jianwei

Volltext

Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy von Niu, Mengke, Yi, Ming, Wu, Yuze, Lyu, Lijuan, He, Qing, Yang, Rui, Zeng, Liang, Shi, Jian, Zhang, Jing, Zhou, Pengfei, Zhang, Tingting, Mei, Qi, Chu, Qian, Wu, Kongming

Volltext

Influence of He injection amount on the microstructure of ion irradiated Cr0.8FeMnNi medium entropy alloy compared with 316L stainless steel von Niu, Mengke, Hashimoto, Naoyuki, Oka, Hiroshi, Sun, Haotian

Volltext